Repackaging of medicine is a hotly debated issue between pharmaceutical companies and parallel traders. Last week the CJEU published its keenly awaited judgments concerning several well-known pharmaceutical companies which provide welcome guidance. Read the article in full on BioTalk here.
| less than a minute read
To repackage or not? Latest CJEU rulings provide guidance for parallel traders of medicines
Get in touch
Get in touch
Get in touch
Get in touch
/Passle/MediaLibrary/Images/2024-11-13-11-08-20-265-673488a4ca20638d587c1800.jpg)
/Passle/64ef1c9c95186b4923406017/MediaLibrary/Images/2024-11-12-13-33-57-556-673359454b3a98d689883f67.png)
/Passle/64ef1c9c95186b4923406017/MediaLibrary/Images/2024-11-11-10-52-22-445-6731e1e610778c48ef2b7265.png)
/Passle/64ef1c9c95186b4923406017/MediaLibrary/Images/2024-10-25-12-24-50-358-671b8e1266037c89ec94f20b.png)